2026-2034年全球自動化免疫檢測儀市場規模、佔有率、趨勢和成長分析報告

預計自動化免疫檢測市場將從 2025 年的 327.6 億美元成長到 2034 年的 1,312.3 億美元，2026 年至 2034 年的複合年成長率為 16.67%。

由於對精準高效診斷檢測的需求日益成長，全球自動化免疫檢測市場正迅速擴張。這些設備廣泛應用於臨床檢查室，用於檢測包括感染疾病、癌症和荷爾蒙失調在內的多種疾病。慢性病和感染疾病在全球範圍內的日益流行，顯著增加了對高通量診斷系統的需求。此外，人們對疾病早期檢測和預防醫學的日益關注，也促使醫療機構採用自動化免疫檢測技術。

技術創新在加速市場成長方面發揮著至關重要的作用。最新的分析儀器靈敏度更高、處理時間更短、自動化程度更高，使檢查室能夠在最大限度減少人為干預的情況下處理大量檢測。先進軟體、資料管理系統和人工智慧的整合也有助於提高診斷準確性和工作流程效率。此外，開發中國家診斷檢查室和醫院的擴張也推動了自動化免疫檢測系統的應用。

隨著醫療保健系統將高效診斷和個人化醫療置於優先地位，自動化免疫檢測市場預計將穩定成長。檢查室自動化投資的增加以及生物技術和製藥領域研發活動的活性化發展，有望為製造商創造新的機會。此外，對就地檢驗和先進檢測設備日益成長的需求，將在未來幾年持續推動技術進步和市場擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球自動化免疫檢測市場：依設備類型分類

• 市場分析、洞察與預測
• 大量銷售
• 試劑租賃

第5章 全球自動化免疫檢測儀市場：依最終用戶分類

• 市場分析、洞察與預測
• 診斷檢查室
• 醫院
• 血庫

第6章：全球自動化免疫檢測儀市場：依技術分類

• 市場分析、洞察與預測
• 酵素螢光免疫分析（ELFA）
• 化學冷光免疫檢測（CLIA）
• 免疫測量（RIA）
• 酵素免疫分析法（ELISA）

第7章 全球自動化免疫檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BioRad Laboratories
  • Roche Diagnostics AG
  • Siemens Healthcare
  • Carolina Liquid Chemistries Corporation
  • Ortho Clinical Diagnostics Corporation
  • Meril Life Sciences
  • Becton Dickinson And Company
  • Luminex Corporation
  • Abbott Laboratories
  • Randox Laboratories
  • BioMerieux SA
  • Arlington Scientific
  • Aesku Diagnostics
  • PerkinElmer Inc
  • F. Hoffmann-La Roche Ltd

The Automated Immunoassay Analyzers Market size is expected to reach USD 131.23 Billion in 2034 from USD 32.76 Billion (2025) growing at a CAGR of 16.67% during 2026-2034.

The global automated immunoassay analyzers market is expanding rapidly due to the growing demand for accurate and efficient diagnostic testing. These analyzers are widely used in clinical laboratories to detect various diseases, including infectious diseases, cancer, and hormonal disorders. The increasing prevalence of chronic and infectious diseases worldwide is significantly boosting the need for high-throughput diagnostic systems. Additionally, the rising focus on early disease detection and preventive healthcare is encouraging healthcare facilities to adopt automated immunoassay technologies.

Technological innovations are playing a crucial role in strengthening market growth. Modern analyzers offer improved sensitivity, faster processing times, and enhanced automation capabilities, which help laboratories handle large volumes of tests with minimal human intervention. Integration of advanced software, data management systems, and artificial intelligence is also improving diagnostic accuracy and workflow efficiency. Furthermore, the expansion of diagnostic laboratories and hospitals in developing countries is contributing to increased adoption of automated immunoassay analyzers.

Looking ahead, the automated immunoassay analyzers market is expected to grow steadily as healthcare systems prioritize efficient diagnostics and personalized medicine. Increasing investments in laboratory automation and growing research activities in biotechnology and pharmaceuticals are likely to create new opportunities for manufacturers. In addition, rising demand for point-of-care testing and advanced laboratory equipment will continue to drive technological advancements and market expansion in the years to come.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Outright Sale
• Reagent Rental/Lease

By End-User

• Diagnostic Laboratories
• Hospitals
• Blood Bank

By Technology

• Enzyme-Linked Fluorescent Immunoassay (ELFA)
• Chemiluminescence Immunoassay (CLIA)
• Radioimmunoassay (RIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)

COMPANIES PROFILED

• BioRad Laboratories, Roche Diagnostics AG, Siemens Healthcare, Carolina Liquid Chemistries Corporation, Ortho Clinical Diagnostics Corporation, Meril Life Sciences, Becton Dickinson and Company, Luminex Corporation, Abbott Laboratories, Randox Laboratories, BioMerieux SA, Arlington Scientific, Aesku Diagnostics, PerkinElmer Inc, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Outright Sale Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Rental/Lease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Blood Bank Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Enzyme-Linked Fluorescent Immunoassay (ELFA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chemiluminescence Immunoassay (CLIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Radioimmunoassay (RIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By End-user
  • 7.2.3 By Technology
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By End-user
  • 7.3.3 By Technology
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By End-user
  • 7.4.3 By Technology
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By End-user
  • 7.5.3 By Technology
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By End-user
  • 7.6.3 By Technology
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BioRad Laboratories
  • 9.2.2 Roche Diagnostics AG
  • 9.2.3 Siemens Healthcare
  • 9.2.4 Carolina Liquid Chemistries Corporation
  • 9.2.5 Ortho Clinical Diagnostics Corporation
  • 9.2.6 Meril Life Sciences
  • 9.2.7 Becton Dickinson And Company
  • 9.2.8 Luminex Corporation
  • 9.2.9 Abbott Laboratories
  • 9.2.10 Randox Laboratories
  • 9.2.11 BioMerieux S.A
  • 9.2.12 Arlington Scientific
  • 9.2.13 Aesku Diagnostics
  • 9.2.14 PerkinElmer Inc
  • 9.2.15 F. Hoffmann-La Roche Ltd